Brief: Jacobio Pharmaceuticals - HY Loss Rmb127.8 Million Versus Loss Of Rmb136.6 Million
23/08/2022 15:08
Jacobio Pharmaceuticals Group Co Ltd 1167.HK :
* JACOBIO PHARMACEUTICALS - HY LOSS RMB127.8 MILLION VERSUS
LOSS
OF RMB136.6 MILLION
* JACOBIO PHARMACEUTICALS - RECORDED REVENUE RMB54.7 MILLION
FOR
SIX MONTHS
Source text for Eikon: ID:
Further company coverage: 1167.HK
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan